These 3 dividend shares jumped 15% per month – more? News ad

Since the company’s stock market continues to fall, investors turn their attention to defensive investments. Dividend shares have always been the favorite of investors, when prices begin to fall, providing immediate income, which potentially compensate for the fallen prices in other areas.

While dividends are usually not classified as growth shares, some shares hold this trend and combine income with a consistent increase in prices. These four dividend shares have increased the price of shares at least 15% over the past 30 days. Let’s see what investment analysts talk about future payments and price potential.

Gilead Sciences shows a 20% pump per month

Gilead Sciences (Nasdaq: Gild) is a biopharmaceutical company focused on the development and marketing therapy for liver diseases, inflammatory diseases, HIV and much more. It is also one of the few Biomedical shares offering dividends with a current dividend yield of 2.72% as of March 11, 2025. Gilead also increased its dividends over time, with 2.74% of the annual three -year growth.

Guild saw his shares grew by 22% last month. Part of this jump in shares is associated with the latest issue of the company’s profit. In the last quarter, Gilead Sciences announced the value of EPS in the amount of $ 1.90, which is 0.23 US dollars higher than the alleged analysts in the amount of $ 1.67.

A recent increase in institutional investment can also help increase stock prices, since in the fourth quarter of 2024, the procurement of institutional investments increases to $ 6.53 billion. Consensus price purposes set the action to a moderate level of purchase, with a potential decrease in 11% next year.

CVS announces new discoveries, sees that shares for shares are rising

Despite the closure of more than 1000 stores at the beginning of this year, the nationwide network for the health and beauty of CVS Health (NYSE: CVS) watches as promotions grow with its recently declared reorganization. According to CNN, CVS plans to open a series of small stores devoted to pharmaceutical items to remain competitive against competitors such as Amazon.com and Target.

This reorganization, as well as a recent surprise of income announcement, has led to 20% of the price of CVS shares over the past 30 days. The company said that the cost of EPS is $ 1.19 on February 12, surpassing the estimates of $ 0.89 per share by more than 33%. This began in an increase in the trend in the target prices of analysts, and it is expected that income will grow by another 15% only next year.

CVS is the highest dividend for S&P 500 investors, with a dividend yield of 4.10% as of March 11, 2025. In addition to invariably competitive profitability, CVS is also a favorite for investors looking for investments in income that can keep up with inflation. His three -year annual dividend growth rate is 9.97%, which led to the payment of about 29% of the company’s available cash flow. However, before buying, pay attention to the current payment coefficient of the company 72.68%, which may indicate the upcoming reduction.

Verizon calls the extremely high dividend profitability

United The largest service service provider of state mobile telephones, Verizon Communications (NYSE: VZ), Will attract the attention of analysts every time it reports on income. The very last quarter was no exception – and although Verizon barely missed the estimates of $ 0.01 per share, its actual performance at $ 1.10 was able to send prices with a stable tendency to increase 16% over the past 30 days.

Promotions are not the only thing that grew with Verizon. The company is also a noticeable choice for a long-term increase in dividends, with a 20-year history of increasing payments. While his annual three -year growth rate is 1.93% less than noteworthy, given the Verizon market capitalization, almost $ 200 billion, which is a high yield of 6.30% as of March 11, 2025.

Current falling prices for shares in the United States can provide the opportunity to purchase dividends for investors, regardless of the fact that VZ is the price within a month. The coefficient of the P/E shares remains low at 11.24, which may indicate that the shares are resold from the market pressure. Institutional investment trends confirm this confidence, and shares acquire $ 7.5 billion in the fourth quarter of 2024.

Companies mentioned in this article:

Company	The current price	Changing the price	Dividend yield	P/e ratio.	Consensus -rating	Consensus target price
CVS Health (CVS)	$ 64.98	-0.4%	4.09%	17.75	Moderate purchase	$ 69.82
Gilead Sciences (Gild)	$ 114.43	-2.4%	2.76%	309.27	Moderate purchase	$ 104.52
Verizon Communications (VZ)	$ 43.51	-6.4%	6.23%	10.51	Moderate purchase	$ 46,11

About Sarah Croat

Experience

Sarah Horvat was a writer for a dividend since 2022.

Areas of experience

Pension investments, long -term retail investments, personal finances

Education

Bachelor of the Arts, University of Arcadia, Glenside

Past experience

Vanguard, Nationalwide, Benzinga and Marketwatch